Novartis has announced more layoffs at its manufacturing plant in Lincoln.
Company spokeswoman Julie Masow tells the Lincoln Journal Star that 75 jobs were eliminated Thursday. That includes 31 positions that were open.
The cuts represent the third phase of restructuring at the plant that Novartis announced in April 2013. In January, the company laid off 27 people and eliminated 58 open positions. In May 2013, it laid off 72 people and eliminated 41 open positions.
The layoffs were in response to the plant shutting down for a year and a half after the Food and Drug Administration found numerous quality-control problems.
The Lincoln plant manufactures Excedrin, TheraFlu and the animal health product Sentinel.
